Aradhana Sarin is on the board of OraSure Technologies, Inc. and President & Director at Alexion Pharmaceuticals, Inc.
In the past Dr. Sarin occupied the position of MD-Healthcare Corporate & Investment Banking at Citizens, Inc. (Austin, Texas) and Managing Director-Healthcare Investment Banking at UBS AG.
Aradhana Sarin received an MBA from Stanford Graduate School of Business.
|12/16/2020||2,510||Derivative/Non-derivative trans. at $157.96 per share.||396,480|
|12/16/2020||6,853||Derivative/Non-derivative trans. at $157.96 per share.||1,082,500|
|12/16/2020||15,371||Award at $0 per share.||0|
|11/30/2020||1,298||Derivative/Non-derivative trans. at $124 per share.||160,952|
|03/02/2020||883||Derivative/Non-derivative trans. at $90.54 per share.||79,947|
|02/28/2020||10,880||Award at $0 per share.||0|
|12/02/2019||5,441||Derivative/Non-derivative trans. at $113.2 per share.||615,922|
|06/21/2019||578||Disposition at $132 per share.||76,296|
|02/28/2019||8,250||Award at $0 per share.||0|
|02/28/2019||267||Derivative/Non-derivative trans. at $132.92 per share.||35,490|